Section 19D1/2: Substance use disorder treatment facility; dispense of opioid antagonist to patient or a legal guardian; promulgation of regulations
173 words·~1 min read·
/ma/part-i/title-xv/chapter-94c/19d1·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 19D1/2.
(a)For the purposes of this section, the following words shall, unless the context clearly requires otherwise, have the following meanings:
''Opioid antagonist'', as defined in section 19B.
''Substance use disorder treatment facility'', a facility licensed or approved by the department or the department of mental health to offer treatment for substance use disorder, including, but not limited to:
(i)withdrawal management services;
(ii)clinical stabilization services;
(iii)transitional support services;
(iv)residential support services;
(v)community behavioral health center services;
(vi)office-based opioid or addiction treatment services; or
(vii)inpatient or outpatient substance use disorder services.
(b)A substance use disorder treatment facility shall, upon discharge of a patient who has:
(i)a history of using opioids;
(ii)been diagnosed with opioid use disorder; or
(iii)experienced an opioid-related overdose, educate the patient on the use of opioid antagonists and dispense not less than 2 doses of an opioid antagonist to the patient or a legal guardian.
(c)The commissioner may promulgate rules and regulations necessary to implement this section.